Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposome bupivacaine versus ropivacaine adjuvant combinations for serratus anterior plane block in thoracoscopic surgery
ChiCTR2500095609Phase 4Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Ropivacaine + dexamethasone group, Ropivacaine + dexmedetomidine group and Bupivacaine liposome group (3 arms). Primary endpoint: Mean NRS pain score. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
bupivacaineropivacainedexamethasonedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500095609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095609.